Home
    Disclaimer
    2C-T molecular structure

    2C-T Stats & Data

    Tesseract 2ct
    Chemical Class Phenethylamine
    Psychoactive Class Psychedelic

    Receptor Profile

    Receptor Actions

    Agonists
    5-HT2A receptor partial agonist
    Other
    potential MAOI properties

    History & Culture

    2C-T emerged from collaborative research between pharmacologist David E. Nichols and chemist Alexander Shulgin, with the compound first appearing in scientific literature in 1976. The substance was subsequently documented in greater detail in Shulgin's 1991 book PiHKAL (Phenethylamines I Have Known And Loved), which described both its synthesis and subjective effects. The compound's nomenclature follows conventions established for the 2C-x series of phenethylamines. The "T" designation derives from the original name for ALEPH-1, which was DOT (indicating a desoxy- modification with a thiomethyl group at the 4-position). This pattern mirrors other 2C compounds that take their names from amphetamine prototypes—2C-B from DOB, 2C-C from DOC, 2C-I from DOI, and so forth. The subsequent numbering of 2C-T variants (2C-T-2, 2C-T-7, and others) reflects the chronological order in which they were conceived rather than indicating any structural relationship, similar to how houses in residential Tokyo are assigned numbers based on construction sequence rather than position along a street. Despite its documentation in foundational psychedelic literature, 2C-T has remained largely obscure in recreational drug markets. The compound is almost unknown on the black market and is rarely encountered through online vendors or traditional distribution channels.

    Effect Profile

    Curated + 2 Reports
    Psychedelic 7.2

    Strong visuals, auditory effects, and body load with moderate headspace

    Visual Intensity×3
    10
    Headspace Depth×3
    6
    Auditory Effects×1
    8
    Body Load / Somatic Effects×1
    8
    Empathogen 3.0

    Strong sensory enhancement with moderate stimulation, low euphoria

    Empathy / Social Openness×3
    0
    Euphoria / Mood Elevation×2
    2
    Stimulation×1
    7
    Sensory Enhancement×1
    10

    Tolerance & Pharmacokinetics

    drugs.wiki

    Tolerance Decay

    Full tolerance 1h Half tolerance 10d Baseline ~14d

    Experience Report Analysis

    Erowid
    2 Reports
    2017–2024 Date Range
    2 With Age Data

    Demographics

    Gender Distribution

    Age Distribution

    Reports Over Time

    Legal Status

    Country Status Notes
    Canada Schedule III Classified as a controlled substance under Schedule III of the Controlled Drugs and Substances Act as of October 31, 2016. Listed as a derivative of 2,5-dimethoxyphenethylamine.
    United Kingdom Class A Controlled under the Misuse of Drugs Act 1971. Designated as Class A due to the phenethylamine catch-all clause, which captures structurally related phenethylamine compounds regardless of explicit scheduling.
    United States Unscheduled (Federal Analog Act applies) Not explicitly scheduled under federal law; however, its structural and pharmacological similarity to scheduled compounds such as 2C-T-7 may subject possession and sale to prosecution under the Federal Analog Act when intended for human consumption. Operation Web Tryp, commenced in 2004, resulted in prosecutions and convictions of online vendors selling similar phenethylamine compounds.
    ← Back to 2C-T